CTLA4 and polyarticular arthritis: To confirm that CTLA-4-Ig suppresses chronic inflammatory polyarthritis, D1BC mice were treated with CTLA-4-Ig or human IgG (hIgG) as a control for weeks 3–10 (two doses per week, 16 doses in total) after the first induction (Fig. 1A).